Dr. Bahrami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 901-595-3300Fax+1 901-595-3100
Education & Training
Mayo Clinic College of Medicine and Science (Rochester) Surgical PathologyFellowship, Selective Pathology, 2009 - 2010
Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Tehran University of Medical Sciences School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2007 - 2025
GA State Medical License 2020 - 2025
MN State Medical License 2008 - 2021
TN State Medical License 2010 - 2021
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Genomic Profiling Uncovers a Broader Spectrum of Dermatofibrosarcoma Protuberans: Implications for Diagnosis and Therapy.Steven Christopher Smith, Kieran Sweeney, Mark G Evans, Kartik Angara, Celia Reynolds
Modern Pathology. 2025-02-14 - Non-myxoid solid variant of extraskeletal myxoid chondrosarcoma: An underrecognized subtype.Sandra Gjorgova Gjeorgjievski, Jatin S Gandhi, Armita Bahrami
Human Pathology. 2025-01-01 - 1 citationsEvaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncolo...Michael R Sargen, Raymond L Barnhill, David E Elder, Susan M Swetter, Victor G Prieto
Journal of Clinical Oncology. 2024-10-04
Journal Articles
- Clinical Genome Sequencing Uncovers Potentially Targetable Truncations and Fusions of MAP3K8 in Spitzoid and Other MelanomasAlberto Pappo, Armita Bahrami, Elizabeth M Azzato, Kim E Nichols, David W Ellison, Nature
- Histiocyte-Rich Rhabdomyoblastic Tumor: Rhabdomyosarcoma, Rhabdomyoma, or Rhabdomyoblastic Tumor of Uncertain Malignant Potential? A Histologically Distinctive Rhabdom...Sharon W Weiss, Andrew L Folpe, Karen J Fritchie, Armita Bahrami, Nature
- Article Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic AnalysesArmita Bahrami, Alberto Pappo, ScienceDirect
Press Mentions
Melanoma Registry Results Shine Light on Rare Pediatric CancerJuly 6th, 2021
Genomic Testing of a Single Patient Reveals a Gene Commonly Mutated in Pediatric MelanomaMarch 5th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
